Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-year Antibody Persistence of MenACWY-CRM in Children
NCT01823536Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2013
- Primary completion
- Oct 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 4 trial of neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen in meningococcal disease, sponsored by Novartis. Started May 2013; status: completed.
02
Drugs
neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01823536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01823536.